Reuters logo
BRIEF-Eiger announces positive phase 2 data with pegylated interferon lambda in hepatitis delta virus infection at the American Association for the Study of Liver Diseases meeting
2017年10月23日 / 中午12点23分 / 1 个月前

BRIEF-Eiger announces positive phase 2 data with pegylated interferon lambda in hepatitis delta virus infection at the American Association for the Study of Liver Diseases meeting

Oct 23 (Reuters) - Eiger Biopharmaceuticals Inc

* Eiger announces positive phase 2 interim 24-week data with pegylated interferon lambda in hepatitis delta virus (HDV) infection at the American Association for the Study of Liver Diseases (AASLD) meeting Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below